World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23293/fullpdf
Reference146 articles.
1. Incidence of myeloproliferative hypereosinophilic syndrome in the Unites States and an estimate of all hypereosinophilic syndrome incidence;Crane;J Allergy Clin Immunol,2010
2. Five years since the discovery of the FIPL1-PDGFRA: What we have learned about the fusion and other molecularly defined eosinophilias;Gotlib;Leukemia,2008
3. Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia;Jovanovic;Blood,2007
4. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia;Pardanani;Blood,2004
5. FIP1L1-PDGFRA in eosinophilic disorders: Prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature;Pardanani;Leuk Res,2006
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Search, Look, and See; Late Recognised Hypereosinophilic Syndrome with Deletion (4) (q12);Clinical and Experimental Health Sciences;2023-06-15
2. Eosinophilic granulomatosis with polyangiitis: A review;Autoimmunity Reviews;2023-01
3. Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5;The Journal of Allergy and Clinical Immunology: In Practice;2022-09
4. Skin manifestations of hypereosinophilic syndrome are polymorphous and difficult to treat: A retrospective cohort study;Annales de Dermatologie et de Vénéréologie;2022-06
5. Hyperéosinophilie chez un patient hospitalisé en psychiatrie : de la déclaration d’une erreur médicamenteuse à la résolution d’un cas de pharmacovigilance;Le Pharmacien Hospitalier et Clinicien;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3